StockNews.com lowered shares of Diversified Healthcare Trust (NASDAQ:DHC – Free Report) from a hold rating to a sell rating in a report issued on Monday morning.
Separately, Royal Bank of Canada increased their target price on Diversified Healthcare Trust from $2.00 to $3.00 and gave the stock an “underperform” rating in a research report on Monday, October 14th.
Diversified Healthcare Trust Trading Down 0.9 %
Diversified Healthcare Trust (NASDAQ:DHC – Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The real estate investment trust reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.46). The business had revenue of $373.64 million during the quarter, compared to the consensus estimate of $376.80 million. Diversified Healthcare Trust had a negative net margin of 26.09% and a negative return on equity of 17.55%. During the same period last year, the firm earned $0.03 EPS. As a group, research analysts anticipate that Diversified Healthcare Trust will post 0.05 EPS for the current year.
Diversified Healthcare Trust Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 14th. Investors of record on Monday, October 28th were paid a dividend of $0.01 per share. The ex-dividend date was Monday, October 28th. This represents a $0.04 annualized dividend and a yield of 1.87%. Diversified Healthcare Trust’s dividend payout ratio is currently -2.48%.
Institutional Trading of Diversified Healthcare Trust
Several institutional investors and hedge funds have recently bought and sold shares of the company. New England Private Wealth Advisors LLC purchased a new position in shares of Diversified Healthcare Trust during the 2nd quarter valued at $62,000. XTX Topco Ltd bought a new position in Diversified Healthcare Trust in the 2nd quarter worth about $74,000. Creative Planning increased its stake in Diversified Healthcare Trust by 14.1% in the 3rd quarter. Creative Planning now owns 22,401 shares of the real estate investment trust’s stock worth $94,000 after acquiring an additional 2,767 shares during the last quarter. Metis Global Partners LLC raised its holdings in shares of Diversified Healthcare Trust by 38.8% in the 3rd quarter. Metis Global Partners LLC now owns 23,610 shares of the real estate investment trust’s stock valued at $99,000 after acquiring an additional 6,603 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Diversified Healthcare Trust by 68.9% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 40,340 shares of the real estate investment trust’s stock valued at $169,000 after acquiring an additional 16,456 shares during the last quarter. 75.98% of the stock is currently owned by hedge funds and other institutional investors.
Diversified Healthcare Trust Company Profile
DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location.
Featured Articles
- Five stocks we like better than Diversified Healthcare Trust
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Using the MarketBeat Stock Split Calculator
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Find and Profitably Trade Stocks at 52-Week Lows
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.